1. Chabriat, H.; Vahedi, K.; Iba-Zizen, M.T.; Joutel, A.;

Nibbio, A.; Nagy, T.G.; Krebs, M.O.; Julien, J.; Dubois,

B.; Ducroca, X.; Levasseur, M.; Homeyer, P.; Mas, J.L.; Lyon-Caen, O.; Tournier-Lasserve, E.; Bousser, M.G. Clinical spectrum of CADASIL: A study of 7 families. Lancet 1995, 346, 934-939.

2. Dichgans, M.; Mayer, M.M.; Uttner, I.; Bruning, R.; Muller-Hocker, J.; Rungger, G.; Ebke, M.; Klockgether, T.; Gasser, T. The phenotypic spectrum of CADASIL: Clinical findings in 102 cases. Ann. Neurol. 1998, 44, 731-739.

3. Kalimo, H.; Ruchoux, M.M.; Viitanen, M.; Kalaria, R.N. CADASIL: A common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol. 2002, 12, 371-384.

4. O'Sullivan, M.; Jarosz, J.M.; Martin, R.J.; Deasy, N.; Powell, J.F.; Markus, H.S. MRI hyperintensities of temporal lobe and external capsule in patients with CADASIL. Neurology 2001, 56, 628-634.

5. Ruchoux, M.M.; Guerouaou, D.; Vandenhaute, B.; Pruvo, J.P.; Vermersch, P.; Leys, D. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencepha-lopathy. Acta Neuropathol. 1995, 89, 500-512.

6. Ruchoux, M.M.; Maurage, C.A. CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J. Neurol. Exp. Neurol. 1997, 56, 947-964.

7. Joutel, A.; Andreux, F.; Gaulis, S.; Domanga, V.; Cecillion, M.; Battail, N.; Piga, N.; Chapon, F.; Godfraind,

C.; Tournier-Lasserve, E. The ectodomain of Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J. Clin. Invest. 2000, 105, 597 -605.

8. Lesnick Oberstien, A.; Van Duinen, S.G.; Van Den Boom, R.; Maat-Schieman, M.L.; Van Buchem, M.A.; Van Houwelingen, H.C.; Hegemann-Kleinn, I.M.; Ferrari, M.D.; Breuning, M.H.; Haan, J. Evaluation of diagnostic Notch3 immunostaining in CADASIL. Acta Neuropathol. 2003, 106, 107-111.

9. Brulin, P.; Godfraind, C.; Leteurtre, E.; Ruchoux, M.M. Morphometric analysis of ultrastructural vascular changes in CADASIL: Analysis of 50 skin biopsy specimens and pathogenic implications. Acta Neuropathol. 2002, 104, 241-248.

10. Tournier-Lasserve, E.; Joutel, A.; Melki, J.; Weissenbach, J.; Lathrop, J.M.; Chabriat, H.; Mas, J.L.; Cabanis, E.A.; Baudrimont, M.; Maciazek, J.; Bach, M.A.; Bousser, M.G. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat. Genet. 1993, 3, 256-259.

11. Joutel, A.; Corpechot, C.; Ducros, A.; Vahedi, K.; Chabriat, H.; Mouton, P.; Alamowitch, S.; Domenga, V.; Cecillion, M.; Marechal, E.; Maciazek, J.; Vayssiere, C.; Cruaud, C.; Cabanis, E.A.; Ruchoux, M.M.; Weissenbach, J.; Bach, J.F.; Bousser, M.G.; Tournier-Lasserve, E. Notch3 mutation in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996, 383, 707-710.

12. Artanavis-Tsakonas, S.; Rand, M.D.; Lake, R.J. Notch signalling cell fate control and signal integration in development. Science 1999, 284, 770-776.

13. Karlsrom, H.; Beatus, P.; Daneus, K.; Chapman, G.; 19. Lendahl, U.; Lundkvist, J.K. A CADASIL-mutated Notch3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling. Proc.

14. Joutel, A.; Chabriat, H.; Vahedi, K.; Domenga, V.; Vayssiere, C.; Ruchoux, M.M.; Lucas, C.; Leys, D.; 20. Bousser, M.G.; Tournier-Lasserve, E. Splice site mutation causing a 7 amino acid Notch 3 in-frame deletion in CADASIL. Neurology 2000, 54, 1874-1875.

15. Joutel, A.; Vahedi, K.; Corpechot, C.; Troesh, A.; Chabriat, H.; Vayssiere, C.; Cruaud, C.; Maciazek, J.; 21. Weissenbach, J.; Bousser, M.G.; Bach, J.F.; Tournier-Lasserve, E. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 1997,

16. Tuominen, S.; Juvonen, V.; Amberla, K.; Jolma, T.; Rinne, J.O.; Tuisku, S.; Kurtki, T.; Marttila, R.; Poyhonen, M.; Savontaus, M.L.; Viitanen, M.; Kalimo, H. Phenotype of a homozygous CADASIL patient with the same R133C 23. Notch3 mutation. Stroke 2001, 32, 1767-1774.

17. Joutel, A.; Dodick, D.D.; Parisi, J.E.; Cecillon, M.; Tournier-Lasserve, E.; Bousser, M.G. De novo mutation 24. in the Notch3 gene causing CADASIL. Ann. Neurol. 2000,

18. Fryxell, K.J.; Soderlund, M.; Jordan, T.V. An animal model for the molecular genetics of CADASIL. Stroke 2001, 32, 6-11.

Ruchoux, M.M.; Domenga, V.; Brulin, P.; Maciazek, J.; Limol, S.; Tournier-Lasserve, E.; Joutel, A. Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephal-opathy. Am. J. Pathol. 2003, 162, 329 - 342. Chabriat, H.; Pappata, S.; Ostergaard, L.; Clark, C.A.; Pachot-Clouard, M.; Vahedi, K.; Jobert, A.; LeBihan, D.; Bousser, M.G. Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke 2000, 31, 1904-1912. Molko, N.; Pappata, S.; Mangin, J.F.; Poupon, C.; Vahedi, K.; Pachot-Clouard, M.; Jobert, A.; Le Bihan, D.; Bousser, M.G.; Chabriat, H. Diffusion tensor imaging study in subcortical gray matter. Stroke 2001, 32, 2049 -2054. Auer, D.P.; Schirmer, T.; Heidenreich, J.O.; Herzog, J.; Putz, B.; Dichgans, M. Altered white and gray matter metabolism in CADASIL: A proton MR spectroscopy and 1H-MRSI study. Neurology 2001, 56, 635-642. Ruchoux, M.M.; Brulin, P.; Brillault, J.; Dehouck, M.P.; Cecchelli, R.; Bataillard, M. Lessons from CADASIL. Ann. N.Y. Acad. Sci. 2002, 977, 224-231. Yonekura, H.; Sakurai, S.; Liu, X.; Migita, H.K.; Wang, H.; Yamagishi, S.I.; Nomura, M.; Abedin, J.; Unoki, H.; Yamamoto, Y.; Yamamoto, H. Placenta growth factor and vascular endothelial growth factor B and C. Expression in microvascular endothelial cells and pericytes. J. Biol. Chem. 1999, 274, 35172 - 35178.

All About Alzheimers

All About Alzheimers

The comprehensive new ebook All About Alzheimers puts everything into perspective. Youll gain insight and awareness into the disease. Learn how to maintain the patients emotional health. Discover tactics you can use to deal with constant life changes. Find out how counselors can help, and when they should intervene. Learn safety precautions that can protect you, your family and your loved one. All About Alzheimers will truly empower you.

Get My Free Ebook

Post a comment